These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Voytovich MH; Simonsen C; Jenssen T; Hjelmesaeth J; Asberg A; Hartmann A Nephrol Dial Transplant; 2005 Feb; 20(2):413-8. PubMed ID: 15615809 [TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033 [TBL] [Abstract][Full Text] [Related]
11. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Hagen M; Hjelmesaeth J; Jenssen T; Morkrid L; Hartmann A Nephrol Dial Transplant; 2003 Oct; 18(10):2154-9. PubMed ID: 13679495 [TBL] [Abstract][Full Text] [Related]
12. Evolution of Glycemic Control and Variability After Kidney Transplant. Aouad LJ; Clayton P; Wyburn KR; Gracey DM; Chadban SJ Transplantation; 2018 Sep; 102(9):1563-1568. PubMed ID: 29494418 [TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Hur KY; Kim MS; Kim YS; Kang ES; Nam JH; Kim SH; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC Diabetes Care; 2007 Mar; 30(3):609-15. PubMed ID: 17327329 [TBL] [Abstract][Full Text] [Related]
14. Comparison of β-Cell Function Between Overweight/Obese Adults and Adolescents Across the Spectrum of Glycemia. Chen ME; Chandramouli AG; Considine RV; Hannon TS; Mather KJ Diabetes Care; 2018 Feb; 41(2):318-325. PubMed ID: 29183909 [TBL] [Abstract][Full Text] [Related]
15. Predictive factors of posttransplant glucose intolerance in Japanese patients with type 1 diabetes after pancreas transplantation. Takahi Y; Miyashita K; Takahara M; Katakami N; Kuroda A; Matsuoka TA; Matsuhisa M; Ito T; Shimomura I Endocr J; 2019 Dec; 66(12):1101-1112. PubMed ID: 31495809 [TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Strøm Halden TA; Åsberg A; Vik K; Hartmann A; Jenssen T Nephrol Dial Transplant; 2014 Apr; 29(4):926-33. PubMed ID: 24452849 [TBL] [Abstract][Full Text] [Related]
17. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study. Cottrell DA J Clin Endocrinol Metab; 1996 Oct; 81(10):3513-9. PubMed ID: 8855794 [TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910 [TBL] [Abstract][Full Text] [Related]
20. Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up. Pararajasingam G; Løgstrup BB; Høfsten DE; Christophersen TB; Auscher S; Hangaard J; Egstrup K BMC Cardiovasc Disord; 2019 May; 19(1):103. PubMed ID: 31046690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]